Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.510
+0.050 (10.80%)
At close: Dec 5, 2025, 4:00 PM EST
0.510
-0.000 (-0.04%)
After-hours: Dec 5, 2025, 7:59 PM EST
Intensity Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 7.07 | 2.59 | 8.56 | 1.31 | 4.54 | 9.32 | Upgrade
|
| Short-Term Investments | - | - | 6.22 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 7.07 | 2.59 | 14.78 | 1.31 | 4.54 | 9.32 | Upgrade
|
| Cash Growth | 154.03% | -82.47% | 1026.22% | -71.10% | -51.28% | 10.99% | Upgrade
|
| Other Receivables | - | - | - | - | 0.05 | 0.05 | Upgrade
|
| Receivables | - | - | - | - | 0.05 | 0.05 | Upgrade
|
| Prepaid Expenses | 1.12 | 0.77 | 0.69 | 0.06 | 0.07 | 0.07 | Upgrade
|
| Other Current Assets | - | - | - | 0.08 | 0.07 | 0.05 | Upgrade
|
| Total Current Assets | 8.19 | 3.36 | 15.46 | 1.45 | 4.73 | 9.48 | Upgrade
|
| Property, Plant & Equipment | 0.1 | 0.12 | 0.15 | 0.14 | 0.32 | 0.49 | Upgrade
|
| Other Long-Term Assets | 1.3 | 1.3 | 1.68 | 0.17 | 0.17 | 0.18 | Upgrade
|
| Total Assets | 9.59 | 4.78 | 17.3 | 1.76 | 5.22 | 10.15 | Upgrade
|
| Accounts Payable | 1.68 | 1.22 | 3.05 | 0.6 | 0.17 | 0.22 | Upgrade
|
| Accrued Expenses | 0.56 | 0.51 | 0.89 | 0.33 | 0.34 | 0.25 | Upgrade
|
| Short-Term Debt | - | - | - | 4.35 | 2.02 | - | Upgrade
|
| Current Portion of Leases | 0.03 | 0.03 | 0.02 | 0.14 | 0.18 | 0.17 | Upgrade
|
| Other Current Liabilities | - | - | - | 1.39 | 1.01 | 0.71 | Upgrade
|
| Total Current Liabilities | 2.28 | 1.76 | 3.96 | 6.82 | 3.72 | 1.35 | Upgrade
|
| Long-Term Leases | 0.09 | 0.11 | 0.14 | - | 0.14 | 0.33 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Total Liabilities | 2.36 | 1.87 | 4.13 | 6.86 | 3.9 | 1.71 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | - | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 82.56 | 69.7 | 63.68 | 23.56 | 22.39 | 21.67 | Upgrade
|
| Retained Earnings | -75.34 | -66.78 | -50.52 | -38.65 | -31.07 | -23.18 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | - | -0.05 | Upgrade
|
| Total Common Equity | 7.22 | 2.92 | 13.16 | -15.1 | -8.68 | -1.56 | Upgrade
|
| Shareholders' Equity | 7.22 | 2.92 | 13.16 | -5.1 | 1.32 | 8.44 | Upgrade
|
| Total Liabilities & Equity | 9.59 | 4.78 | 17.3 | 1.76 | 5.22 | 10.15 | Upgrade
|
| Total Debt | 0.12 | 0.14 | 0.16 | 4.49 | 2.34 | 0.5 | Upgrade
|
| Net Cash (Debt) | 6.95 | 2.45 | 14.62 | -3.18 | 2.2 | 8.82 | Upgrade
|
| Net Cash Growth | 163.52% | -83.23% | - | - | -75.09% | 8.43% | Upgrade
|
| Net Cash Per Share | 0.30 | 0.18 | 1.70 | -0.93 | 0.64 | 2.59 | Upgrade
|
| Filing Date Shares Outstanding | 60.06 | 15.18 | 13.71 | 3.41 | 3.41 | 3.41 | Upgrade
|
| Total Common Shares Outstanding | 49.07 | 15.12 | 13.71 | 3.41 | 3.41 | 3.41 | Upgrade
|
| Working Capital | 5.91 | 1.61 | 11.51 | -5.37 | 1.01 | 8.13 | Upgrade
|
| Book Value Per Share | 0.15 | 0.19 | 0.96 | -4.43 | -2.55 | -0.46 | Upgrade
|
| Tangible Book Value | 7.22 | 2.92 | 13.16 | -15.1 | -8.68 | -1.56 | Upgrade
|
| Tangible Book Value Per Share | 0.15 | 0.19 | 0.96 | -4.43 | -2.55 | -0.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.